Business briefs: Amgen Inc. downsizing

The biotechnology company, Amgen Inc., plans to cut up to 14 percent of its work force. The Thousand Oaks-based firm said it plans to reduce its work force by 12 percent to 14 percent, or between 2,200 and 2,600 positions, and take with a restructuring charge between $600 million and $700 million. Amgen (AMGN) also lowered its profit guidance because of slimmer-than-expected sales of its anemia drug.

PENNIES

Rising metal prices have prompted lawmakers to consider dropping the zinc from pennies. Jarden Zinc Products (JAH), the government’s sole supplier of “penny blanks,” previously fought legislation allowing retailers to round off cash transactions, effectively eliminating the penny. The company has said it would be willing to consider producing blanks in other metals.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Approval process for Balboa Reservoir project gets underway

The Balboa Reservoir project received the first approval on Thursday needed to… Continue reading

Emergency housing made available for domestic violence survivors

Victims of abuse who are trapped during lockdown may have somewhere to turn

Sunset supervisor wants to keep Great Highway car free during crisis

Mar eyes empty roadway as ideal space for bicylists and pedestrians

Most Read